Search results for: 'biologics contracts development ad manufacturing'

13 Sep 2021  |  North America  |  Market Research

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

Infographics

×

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

This Frost & Sullivan analysis examines the technological and industrial landscape of sustainable manufacturing for flexible electronics. It reviews the top 10 technologies and trends, assessing their relevance, maturity, and potential to enable environmentally responsible, high-efficiency production. It explores how these technologies can reduce m...

Biologics, particularly peptide and protein therapies, are a rapidly growing therapeutic area because they can target complex biological pathways with high efficacy. These therapies are becoming important in oncology, metabolic disease, and autoimmune conditions supported by the growing global disease burden and growth in areas such as GLP-1s and m...

Biological age tracking is emerging as a complementary approach to understanding human health, offering a more nuanced assessment of physiological state than chronological age alone. This report examines the evolving landscape of biological aging platforms, with a focus on molecular and omics-based technologies including epigenetic, proteomic, tran...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments for intelligent drug discovery solutions, precision oncology and novel biologics. The TOE also comprises innovations across stem cell therapies and radiotherapies.The Life Science, Health & Wellness TOE will feature d...

25 Jul 2016  |  Europe  |  Market Research

Analysis of the Global Biologics API Market

Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies

Infographics

×

This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose dis...

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

10 Sep 2024  |  Global  |  Technology Research

Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing

Increasing demand for small molecule drugs is driving the growth of modular and automated technologies in pharmaceutical manufacturing

Infographics

×

This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized...